Correlation Between Centessa Pharmaceuticals and Rezolute
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Rezolute at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Rezolute into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Rezolute, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Rezolute and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Rezolute. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Rezolute.
Diversification Opportunities for Centessa Pharmaceuticals and Rezolute
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Centessa and Rezolute is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Rezolute in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rezolute and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Rezolute. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rezolute has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Rezolute go up and down completely randomly.
Pair Corralation between Centessa Pharmaceuticals and Rezolute
Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 1.05 times more return on investment than Rezolute. However, Centessa Pharmaceuticals is 1.05 times more volatile than Rezolute. It trades about 0.18 of its potential returns per unit of risk. Rezolute is currently generating about -0.09 per unit of risk. If you would invest 1,589 in Centessa Pharmaceuticals PLC on September 3, 2024 and sell it today you would earn a total of 202.00 from holding Centessa Pharmaceuticals PLC or generate 12.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Centessa Pharmaceuticals PLC vs. Rezolute
Performance |
| Timeline |
| Centessa Pharmaceuticals |
| Rezolute |
Centessa Pharmaceuticals and Rezolute Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Centessa Pharmaceuticals and Rezolute
The main advantage of trading using opposite Centessa Pharmaceuticals and Rezolute positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Rezolute can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rezolute will offset losses from the drop in Rezolute's long position.The idea behind Centessa Pharmaceuticals PLC and Rezolute pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Rezolute vs. DiaMedica Therapeutics | Rezolute vs. Lyra Therapeutics | Rezolute vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets |